Ledger.Open graph →
SEC Form D · filed May 3, 2024

Endeavor Biomedicines, Inc

Offering
$132.6M
Sold
$132.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Karan C. Takhar · San Diego, CADirectorEnoch Kariuki · San Diego, CAExecChris Krueger · San Francisco, CAExecRoger Richer · Vancouver, British Columbia, CanadaDirectorWing C. Lam · San Diego, CADirectorPatrick G. Enright · San Diego, CADirectorAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorChris Krueger · San Francisco, CAExecVishaal Turakhia · San Diego, CAExecKeli M. Callaghan · Miami, FLDirectorVishaal Turakhia · San Diego, CAExecMonal C. Mehta · San Diego, CADirectorAndrew C. Hakim · GRAND RAPIDS, MIExec · DirectorKaran C. Takhar · San Diego, CADirectorMiguel De Los Rios · San Diego, CAExecTodd Underwood · Portland, ORExecTaryn M. Naidu · Miami, FLExecPhilip Dickie · Grand Cayman, Cayman IslandsDirectorMatthew P. Franz · GRAND RAPIDS, MIDirectorBhavik M. Patel · Miami, FLDirectorJonathan Gazdak · Tampa, FLDirectorJohn Hood · San Diego, CAExec · DirectorBernard Davitian · San Diego, CADirectorDaniel H. Shuart · GRAND RAPIDS, MIDirectorFrancis Macdonald · Vancouver, British Columbia, CanadaExec · DirectorEnoch Kariuki · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗